Navigation Links
New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
Date:6/3/2013

FRANKLIN LAKES, N.J., June 3, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the launch of BD Neopak™, a new glass prefillable syringe system specifically engineered for the administration of biopharmaceutical injectable drugs. This new product is designed to address industry challenges in developing, manufacturing and marketing biologic drugs to patients.

The BD Neopak™ Glass Prefillable Syringe provides biopharmaceutical companies and patients with an even higher level of quality and enhanced container and device integration. Developed with a quality-by-design approach, the product is manufactured in a fully indexed process, which eliminates glass-to-glass contact resulting in fewer visual defects and increased glass strength. The new process reduces silicone levels while maintaining the appropriate glide force functionality. Through tighter dimensional tolerances and by limiting the dead volume space, the BD Neopak™ Glass Prefillable Syringe also reduces waste and overfilling of the biologic drug.

"In today's environment, regulatory authorities, patients and prescribers demand higher quality and more reliability in injectable drug delivery systems," said Claude Dartiguelongue, President, BD Medical – Pharmaceutical Systems. "The BD Neopak™ Glass Prefillable Syringe is designed to reduce risks associated with primary container and drug interactions and enable our customers' drug products speed to market safely and effectively."

Seven of the top 10 selling drugs worldwide and more than half of drugs currently in development are biologics.[i] To support drug development with the BD Neopak™ Glass Prefillable Syringe, BD offers customers a full range of drug compatibility assessment services, drug and system-related functional requirements and regulatory expertise for registration support for the product.

The BD Neopak™ Glass Prefillable Syringe also offers further customization options for pharmaceutical partners with sensitive drugs through BD XSi™ cross-linked silicone technology (which reduces sub-visible particles while maintaining syringe functionality) and ultralow tungsten technology. Furthermore, BD's advances in needle technology improve the patient experience and ensure reliable flow mechanics with more viscous drug formulations.[ii]

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

[i] EvaluatePharma (June 2012).

[ii] Data on file at BD

Contact:
Jamie Yacco
Public Relations
(201) 847-4796
Jamie_Yacco@bd.com

 


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan
2. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
3. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
4. BD Announces Agreement to Acquire Safety Syringes, Inc.
5. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
6. Microneedle Drug Patches, Syringes & Systems
7. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
8. Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects
9. Prefilled Syringes 2013 Market Report
10. Dual Chamber Syringes & Injectors
11. Integrated Safety Syringes to 2016: Devices, Markets Players and Prospects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):